(Hypertension. 1997;30:288-294.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Pharmacology, School of Medicine, East Carolina University, Greenville, NC.
Correspondence to Abdel A. Abdel-Rahman, PhD, Department of Pharmacology, School of Medicine, East Carolina University, Greenville, NC 27858. E-mail rahman{at}brody.med.ecu.edu
| Abstract |
|---|
|
|
|---|
Key Words: alcohol, ethyl blood pressure cardiac output clonidine hydralazine peripheral resistance
| Introduction |
|---|
|
|
|---|
The role of CO and TPR in centrally and peripherally
mediated hypotensive responses has been variable. Studies in
humans11 12 and experimental animals13 14
have shown that the hypotensive effect of clonidine results mainly from
a reduction in CO, since TPR remained unchanged. A recent study from
our laboratory15 showed that clonidine-evoked hypotension
in ABD rats is mediated exclusively by a reduction in CO through a
centrally mediated sympathoinhibitory action. The
peripheral resistance, even though elevated in ABD rats
compared with SO rats, was not influenced by clonidine.15
It is notable that the antihypertensive effect of clonidine involves
activation of imidazoline receptors and
2-adrenoceptors
in the lower brain stem region leading to a reduction in central
sympathetic tone and subsequently a fall in BP.16 17
Contrary to clonidine, hydralazine lowers BP predominantly via
a reduction in TPR; HR and CO are increased by a baroreflex-mediated
increase in sympathetic outflow to the heart.18 19 It is
not clear whether differences in the relative contribution of CO and
TPR to the hypotensive effects of clonidine and hydralazine
could explain the differential effect of ethanol on these responses in
previous studies.1 3 Reports on the effect of ethanol on
CO and TPR have been controversial. CO may be
increased,20 21 decreased,22 23 or not
affected20 24 by ethanol administration. Various effects
of ethanol on TPR have also been reported.20 21 22 23 24 These
discrepancies have been attributed to differences in baseline levels of
measured variables, animal species and strain, dose and route of
administration of ethanol and whether anesthetized or conscious
animals were used.20 21 22 23 24 None of the reported studies has
investigated the role of CO and TPR in the adverse
hemodynamic interaction between ethanol and
clonidine.
The main objective of the present study was to investigate the role
of CO and TPR in the ethanol-evoked attenuation of the hypotensive
effect of clonidine. Experiments were designed to evaluate the
influence of subsequent ethanol administration on
hemodynamic responses elicited by clonidine in
conscious freely moving rats. Changes in MAP, HR, CO, SV, and TPR
evoked by clonidine and subsequently administered ethanol (1
g/kg) or an equal volume of saline were watched for 70 minutes.
Because previous studies from this laboratory showed that the
hypotensive effect of clonidine is significantly enhanced in rats after
surgical elimination of aortic depressor nerves compared with a lesser
effect in intact (SO) rats,3 15 25 the conscious ABD rat
model was used in this study to allow better evaluation of
ethanol-clonidine hemodynamic interaction. The reason
for the enhanced hypotensive effect of clonidine in ABD rats has been
investigated in recent studies from our laboratory. Upregulation of
imidazoline receptors26 and
2-adrenoceptors27 in the brain stem, the
main site of the hypotensive action of clonidine,16 17 28
has been suggested as a possible mechanism for the enhanced hypotensive
effect of clonidine in this rat model. Further support for our
hypothesis was sought by studying the effect of ethanol on the
hemodynamic responses elicited by the
peripherally acting drug hydralazine. A dose of
hydralazine that produced hypotension similar to that produced
by clonidine in ABD rats was used to facilitate data
interpretation.
| Methods |
|---|
|
|
|---|
Aortic Baroreceptor Denervation
Aortic barodenervation was accomplished by bilateral transection
of the superior laryngeal, cervical sympathetic, and aortic depressor
nerves after a midline incision in the cervical region as described in
our previous studies.3 6 15 SO rats were prepared by
exposing the relevant nerve trunks without sectioning. PE (4
µg/kg) was injected intravenously before and after
ABD or sham operation. A smaller decrease in HR of ABD rats in response
to similar PE-evoked increase in BP indicated successful
denervation.3 6 15
Measurement of CO
A Cardiomax II (Columbus Instrument) interfaced with an
AT-computer was used for measurement of CO by the thermodilution
technique as described in previous studies,15 29 30
including our own. This arrangement allowed acquisition of data and
computation of CO (mL/min) and SV (µL/beat). In addition to CO and SV
measurements, the CI (CO/100 g body wt, mL ·
min-1 · 100
g-1) and TPR (MAP/CI, mm Hg ·
mL-1 ·
min-1 · 100 g body
wt-1) were calculated.
Finally, the catheters and the thermistor were tunneled subcutaneously and exteriorized at the back of the neck between the scapulae. The catheters were flushed with heparin (200 U/mL) and plugged by stainless steel pins. Incisions were closed by surgical clips and swabbed with povidone-iodine solution. Each rat received an intramuscular injection of 60 000 U of penicillin G benzathine and penicillin G procaine in an aqueous suspension (Durapen) and was housed in a separate cage.
Protocols and Experimental Groups
Ethanol-Clonidine Hemodynamic Interaction
A total of 20 experiments were performed on 10 conscious rats, 5
ABD and 5 SO, to investigate the role of CO and TPR in the
antagonistic hemodynamic interaction
between ethanol and clonidine. Each rat was used twice on two
consecutive days, ie, 48 and 72 hours after instrumentation. Treatment,
ethanol or saline, was randomized as explained below.
Hemodynamic variables (BP, HR, CO, SV, and TPR)
were measured before and at 5 minutes (anesthetized state) and
at 48 and 72 hours (conscious state) after ABD or sham operation. On
the day of the experiment, the thermistor was connected to a Cardiomax
II for measurement of CO and the arterial catheter was
connected to a pressure transducer for measurement of blood pressure
and heart rate as mentioned above. A period of 30 minutes was allowed
at the beginning of the experiment for stabilization of BP and HR. Each
rat received clonidine (30 µg/kg) intravenously,
and 10 minutes later ethanol (1 g/kg) or an equal volume of
saline (1.3 mL/kg) was infused intravenously over 1 minute.
Changes in BP, HR, CO, SV, and TPR were followed for an additional 60
minutes. Ethanol (1 g/kg) was administered as 95% in a volume
of 1.3 mL/kg body wt as described in our previous
studies.2 3 The administration of ethanol and saline was
randomized on the 2 days of the experiment. In a previous study, we
have shown that ethanol-clonidine interaction is both reversible and
reproducible.1
Ethanol-Hydralazine Hemodynamic Interaction
This experiment examined the effect of ethanol on
peripherally mediated hemodynamic responses
evoked by hydralazine. Two additional groups of rats (one ABD
and one SO, n=7 to 8) instrumented for measurement of BP, HR, and CO
were used in this experiment. Hydralazine (0.5 mg/kg)
was administered intravenously, and 10 minutes later
randomized administration of ethanol (1 g/kg) or an equal volume
of saline was performed on day 1 of the study. Ethanol and saline
treatments were crossed over on day 2 as described in our previous
study.1 Changes in BP, HR, CO, SV, and TPR evoked by
hydralazine and subsequent ethanol or saline administration
were measured over a 70-minute period.
Drugs
Clonidine hydrochloride, phenylephrine
hydrochloride, hydralazine hydrochloride (Sigma Chemical Co),
methohexital sodium (Brevital, Eli Lilly & Co), povidone-iodine
solution (Norton Co), and Durapen (Vedco, Inc) were purchased from
commercial vendors.
Statistical Analysis
Values are presented as mean±SEM. Mean
arterial pressure (MAP) was calculated as
diastolic pressure plus one-third pulse pressure
(systolic pressure minus diastolic pressures). The
baroreflex sensitivity tested by PE was measured by calculation of the
ratio
HR/
MAP.3 6 ANOVA followed by a Newman-Keuls
post hoc analysis was used to analyze the effects of
subsequent ethanol or saline administration on
hemodynamic responses (BP, HR, CO, SV, and TPR) evoked
by clonidine or hydralazine. Simple contrasts were made with
Student's t test. A value of P<.05 was
considered significant.
| Results |
|---|
|
|
|---|
HR/
MAP ratio by
approximately 40% (from -0.80±0.02 to -0.47±0.03 beats ·
min-1 · mm
Hg-1) compared with no change after sham
operation (from -0.84±0.05 to -0.83±0.05 beats ·
min-1 · mm
Hg-1), which indicated successful
denervation.
The hemodynamic effects evoked by clonidine and
subsequent ethanol or saline administration in conscious rats 48 and 72
hours after surgery are shown in Figs 1
and 2
. Baseline BP and HR were similar in
conscious ABD and SO rats (Fig 1
). On the other hand, the TPR (4.0±0.1
versus 2.8±0.1 mm Hg ·
mL-1 ·
min-1 · 100
g-1; Fig 2E
and 2F
) was significantly
(P<.05) enhanced, whereas CI (27±1 versus 41±3 mL
· min-1 · 100
g-1; Fig 2A
and 2B
) and SV (210±10 versus
327±19 µL/beat; Fig 2C
and 2D
) were significantly
(P<.05) decreased in ABD compared with SO rats. Clonidine
(30 µg/kg, IV) elicited significantly (P<.05)
greater hypotensive responses in conscious ABD compared with SO rats
(Fig 1A
and 1B
). A maximal hypotensive response to clonidine of 18±1
and 6±1 mm Hg was obtained in ABD and SO rats, respectively.
The HR of both groups of rats showed substantial decreases after
clonidine (Fig 1C
and 1D
). The initial bradycardic response was
significantly (P<.05) smaller in ABD rats (47±2 versus
120±11 beats/min) and the recovery to baseline levels was slower
compared with SO rats (Fig 1C
and 1D
). The hypotensive effect of
clonidine in ABD rats coincided with significant (P<.05)
decreases in CI (from 29±2.8 to 18±0.9 mL ·
min-1 · 100
g-1; Fig 2B
) caused by concomitant decreases
in HR (Fig 1D
) and SV (Fig 2D
). Subsequent administration of ethanol (1
g/kg) counteracted the hypotensive effect of clonidine and
raised the BP to levels higher than the corresponding preclonidine
levels (Fig 1B
). The pressor effect of ethanol in ABD rats continued
for at least 40 minutes and was associated with significant increases
in CI (Fig 2B
) and SV (Fig 2D
) compared with the corresponding
postsaline values. In contrast, the TPR was significantly
(P<.05) reduced after ethanol administration (Fig 2F
). In
SO rats, the only effect of ethanol was the significant increase in SV
(Fig 2C
). This response resulted in slight increases in BP (Fig 1A
) and
CI (Fig 2A
), but differences were not significant when compared with
the clonidine-saline group.
|
|
Ethanol-Hydralazine Hemodynamic Interaction
The hemodynamic effects of hydralazine and
subsequent ethanol or saline administration in conscious unrestrained
ABD and SO rats are depicted in Figs 3
and 4
. Generally, ABD-evoked changes in
TPR and CI, detailed above, did not significantly influence the
hypotensive effect of hydralazine. Hydralazine (0.5
mg/kg, IV) decreased BP similarly in ABD and SO rats before
ethanol or saline administration (Fig 3A
and 3B
). Despite a
significantly (P<.05) higher baseline TPR in ABD rats, the
reductions in TPR from the respective baseline values elicited by
hydralazine were similar in ABD and SO rats and amounted to
approximately 55% (Fig 4E
and 4F
). Similarly, the reflex increase in
CI that accompanied hydralazine-evoked hypotension was
approximately twofold the respective baseline values in ABD and SO rats
(Fig 4A
and 4B
). The increase in CI was associated with increases in HR
(Fig 3C
and 3D
) and SV (Fig 4C
and 4D
). The maximal hypotensive
response elicited by hydralazine was approximately 20
mm Hg (Fig 3B
), which was similar to that produced by clonidine in
ABD rats (Fig 1B
). Treatment with ethanol (1 g/kg IV) during the
hydralazine-evoked hypotension in ABD and SO rats elicited a
brief increase in BP (Fig 3A
and 3B
) and TPR (Fig 4E
and 4F
) that
lasted less than 5 minutes after which the MAP and TPR responses to
hydralazine were similar in the treatment and control groups.
The reflex elevation in CI (Fig 4A
) produced by
hydralazine-evoked hypotension in SO rats was counteracted by
ethanol administration because of significant (P<.05)
decreases in HR (Fig 3C
) and SV (Fig 4C
). In ABD rats, ethanol
counteracted the hydralazine-evoked increases in CI at 5
minutes only (Fig 4B
) and HR at 50 and 70 minutes (Fig 3D
) but had no
effect on SV (Fig 4D
).
|
|
| Discussion |
|---|
|
|
|---|
Our previous studies showed that ethanol counteracts hypotensive responses to clonidine after both acute1 3 and chronic31 administration. However, these previous studies were based on changes in BP, and no measurement of CI or TPR was made. The present study evaluated the relative contribution of CO and TPR to the pressor effect of ethanol observed when administered during clonidine-evoked hypotension. To facilitate data interpretation, the effect of ethanol was also investigated on the hypotensive response elicited by hydralazine and on the associated CO and TPR responses. A dose of hydralazine that produced hypotension similar to that produced by clonidine was used in the present study.
The findings of the present study that ethanol counteracted clonidine- but not hydralazine-evoked hypotension confirm our previous findings in ABD and spontaneously hypertensive rats.1 2 3 Furthermore, the present investigation showed that the differential effect of ethanol on hypotensive responses produced by clonidine and hydralazine may relate, at least in part, to the relative contribution of peripheral hemodynamics (CO and TPR) to these responses. Results of this study and previous studies13 15 18 19 demonstrated that the hypotensive effects of clonidine and hydralazine involve reductions in CO and TPR, respectively. The reduction in CO produced by clonidine seems to result from the inhibition of central sympathetic tone. This view is supported by a recent study from our laboratory15 that showed that the hypotensive and sympathoinhibitory responses to intracisternally administered clonidine in ABD rats are associated with significant reductions in CO. The ability of clonidine-evoked sympathoinhibition to reduce CO but not TPR may be explained by the nonuniformity in the central control of sympathetic outflows to peripheral tissues32 and therefore the responsiveness of these tissues to the sympathoinhibitory action of clonidine.33 Furthermore, clonidine-evoked sympathoinhibition may have affected the capacitance vessels (venodilatation), which consequently leads to a reduction in venous return and CO.34
The ability of ethanol to counteract clonidine-evoked hypotension may be explained by its ability to enhance the sympathetic neural activity.35 36 37 Also, we have shown that microinjection of ethanol into the anterior hypothalamus and rostral ventrolateral medulla increased sympathetic neural activity in rats.38 The latter is the major site of action of clonidine.28 It is notable that ethanol acutely administered to humans8 39 and rats6 40 elicits a modest and short-lived pressor effect despite its sympathoexcitatory action.35 36 37 38 In a recent study we demonstrated in intact Sprague-Dawley rats that the hemodynamic effects of ethanol administered alone depended on the dose used.20 At a dose of 0.5 g/kg, ethanol increased CO that was sympathetically mediated and resulted, at least in part, from ethanol-evoked reduction in TPR.20 At a higher dose (1 g/kg), it seems that the centrally mediated sympathoexcitatory action of ethanol38 counteracted its peripheral vasodilatory effect7 10 because TPR was modestly reduced while CO remained unchanged.20 Therefore, the dose of ethanol used in the present study (1 g/kg) does not significantly change CO when administered to Sprague Dawley rats in the absence of clonidine. Nonetheless, the current study demonstrates for the first time that this dose of ethanol significantly increased CO when basal sympathetic tone was inhibited by previous clonidine administration. The increase in CO seems to outweigh the modest inhibitory effect of ethanol on TPR and to have resulted in an enhanced and longer-lasting pressor effect of ethanol. In effect, a previous study from our laboratory3 showed that the ability of ethanol to enhance sympathetic tone depends on the magnitude of the preexisting activity of the sympathetic nervous system. A larger fall in sympathetic activity developed by clonidine in ABD, compared with SO, rats has been associated with a greater sympathoexcitatory response to subsequently administered ethanol.3 Taken together, these findings suggest that the sympathetically mediated changes in CO play an important role in mediating the adverse hemodynamic interaction between ethanol and clonidine.
Unlike the case with clonidine, results of this study showed that the hypotensive effect of hydralazine in ABD and SO rats resulted exclusively from a peripherally mediated reduction in TPR. The increases in HR, CO, and SV that accompanied the vasodilatory effect of hydralazine result from compensatory baroreflex-mediated increases in sympathetic outflow to the heart.19 41 It is conceivable to assume that the presence of a high sympathetic tone in hydralazine-treated rats may have masked the sympathoexcitatory action of ethanol and hence its ability to counteract the hydralazine-evoked hypotension. With this in mind, the present finding that ethanol significantly lowered CO in hydralazine-treated SO rats may be accounted for by a predominant myocardial depressant effect of ethanol. It is notable that the net cardiac response to ethanol is the algebraic sum of two opposite effects, a direct cardiac depressant action and an indirect sympathetically mediated cardiac stimulatory action.42 Further support for this notion is the enhanced bradycardic effect of ethanol in the spontaneously hypertensive rat40 in which an enhanced sympathetic activity is exhibited.43
It is noteworthy that the present study investigated the role of CO and TPR in the interaction of ethanol with antihypertensive agents. However, the possibility must be considered that the myocardial and metabolic effects of ethanol may have contributed to its interaction with antihypertensive drugs. Reported findings have shown that ethanol decreases myocardial contractility (dP/dt) and left ventricular work.44 45 These effects of ethanol may relate to its ability to inhibit the attachment of calcium to contractile proteins or to significantly alter mitochondrial function.46 Whether pretreatment with clonidine or hydralazine, which elicit opposite effects on cardiac sympathetic activity, influenced the cardiac effects of ethanol needs to be investigated.
As discussed above, the direct cardiac depressant action of ethanol42 may not manifest because of its direct sympathoexcitatory action.35 36 37 Therefore, factors that influence the sympathetic activity are expected to modify the latter action of ethanol and hence the net effect on cardiac function. The ABD rat model, chosen because it unmasks the hypotensive action of clonidine,3 15 exhibits elevated sympathetic activity even when BP is restored to normal levels.15 25 The elevated sympathetic activity in this animal model in conjunction with hypotensive drugs that modified such activity may be an important factor in determining the net effect of ethanol on CO. For example, ethanol significantly decreased hydralazine-evoked increases in CO in SO rats but not in ABD rats. This differential effect of ethanol appears to involve differences in its effects on SV in SO (decrease) and ABD (no change) rats, since HR was significantly reduced by ethanol in the two preparations. Given that hydralazine elicited similar increases in CO in ABD and SO rats, the presence of a significantly lower CO in ABD rats compared with SO rats before hydralazine administration may have limited the capacity of ethanol to decrease CO in ABD rats. Furthermore, the ability of ethanol to counteract clonidine-evoked decreases in CO in ABD rats but not in SO rats coincided with a markedly lower CO in ABD rats. That ABD enhances the sympathetic nervous system activity, which is known to play a key role in the interaction between ethanol and antihypertensive agents,2 3 may explain, at least in part, the different effects of ethanol on CO when sympathetic activity is increased (hydralazine) or decreased (clonidine).
In summary, the present findings suggest that ethanol counteracts the hypotensive response to clonidine via a mechanism that involves, at least in part, reversal of clonidine-evoked decreases in CO and SV. In contrast, ethanol had no effect on the peripherally mediated hypotensive response to hydralazine. Interestingly, ethanol also counteracted the compensatory increases in CO, which resulted from hydralazine-evoked hypotension. These findings suggest that the preexisting sympathetic tone determines the final effect of ethanol on CO and TPR and hence on blood pressure.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received December 2, 1996; first decision January 2, 1997; accepted January 24, 1997.
| References |
|---|
|
|
|---|
2-Adrenoceptors: classification, localization, mechanisms and
targets for drugs. J Med Chem. 1982;25:1389-1401.[Medline]
[Order article via Infotrieve]
2-adrenoceptors in the nucleus tractus
solitarius and rostral ventrolateral medulla: an
autoradiographic study. Neuroscience. 1997;79:581-590.[Medline]
[Order article via Infotrieve]
2-adrenoceptors in the ventrolateral medulla. Eur
J Pharmacol. 1987;134:1-13.[Medline]
[Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. ALI, S. A. LEONARD, C. A. KUKOLY, W. JAMES METZGER, W. R. WOOLES, J. F. MCGINTY, M. TANAKA, A. SANDRASAGRA, and J. W. NYCE Absorption, Distribution, Metabolism, and Excretion of a Respirable Antisense Oligonucleotide for Asthma Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 989 - 993. [Abstract] [Full Text] |
||||
![]() |
M. M. El-Mas and A. A. Abdel-Rahman Ethanol Counteraction of I1-Imidazoline but Not Alpha-2 Adrenergic Receptor-Mediated Reduction in Vascular Resistance in Conscious Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 455 - 462. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |